ENTITY

Exact Sciences (EXAS US)

38
Analysis
Health CareUnited States
Exact Sciences Corp., is focused on developing and commercializing a non-invasive molecular screening test for the early detection and prevention of colorectal cancer. The Company's test is a stool-based DNA test that identifies both pre-cancer and cancer by detecting genetic mutations in colorectal cancer cells.
more
bullishExact Sciences
09 Aug 2024 23:00

Exact Sciences Corporation: Expansion into Care Gap Programs & Other Major Drivers

Exact Sciences Corp. recently reported its second quarter 2024 earnings demonstrating strong performance and strategic advancements in its...

Logo
256 Views
Share
bullishExact Sciences
24 May 2024 14:00

Exact Sciences Corporation: Leveraging Health Systems and Electronic Ordering Channels To Catalyze Growth! - Major Drivers

Exact Sciences Corporation's first quarter 2024 earnings. The quarter demonstrated robust performance with first quarter revenue growing by 6% to...

Logo
298 Views
Share
bullishExact Sciences
29 Feb 2024 14:00

Exact Sciences Corporation: Launch Of MRD product OncoDetect & Other New Products! - Major Drivers

Exact Sciences Corporation showcased substantial growth and improved profitability throughout 2023. With a 24% increase in core revenue amounting...

Logo
183 Views
Share
bullishExact Sciences
01 Dec 2023 08:05

Exact Sciences Corporation: Cologuard Market Positioning & Long-Term Growth Strategy! - Major Drivers

Exact Sciences Corporation delivered a positive result and managed an all-around beat in the quarter. During the quarter, over 10,000 new...

Logo
130 Views
Share
bearishCarvana
30 Jun 2022 09:55

Liquidity Risk Short Candidates: Carvana, Exact Sciences, Inspire Med, Freshpet, Enviva

Liquidity risk short candidates may not be economically viable given cash flows and capital requirements.  This week we flag Carvana, Exact...

Share
x